Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma

NCT05444088 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: Adebrelimab
DRUG: Bevacizumab
DRUG: SHR-8068

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.